Picture of Immunovia AB (publ) logo

IMMNOV Immunovia AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Immunovia Initiates Consultation Process With Relevant Swedish Unions To Create Best Possible Transition For Affected Employees

Jan 19 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA REALIGNING SWEDISH OPERATIONS WITH STRATEGIC
PRIORITIES AND ITS FOCUS ON THE US COMMERCIALIZATION OF THE
IMMRAY™ PANCAN-D TEST
    * IS REALIGNING ITS SWEDISH OPERATIONS WITH ITS STRATEGIC
PRIORITIES TO DRIVE RESEARCH AND DEVELOPMENT PRODUCTIVITY AND
FOCUS ON US COMMERCIALIZATION OF IMMRAY™ PANCAN-D TEST.
    * HAS INITIATED A CONSULTATION PROCESS WITH RELEVANT SWEDISH
UNIONS TO CREATE BEST POSSIBLE TRANSITION FOR AFFECTED EMPLOYEES
    * WILL PROVIDE AN UPDATE ONCE CONSULTATION PROCESS IS
CONCLUDED

Source text for Eikon:  ID:nWkr2YD39C 
Further company coverage:  IMMNOV.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Immunovia AB (publ)

See all news